Validation of the SLE-DAS responder index as an accurate and feasible endpoint for SLE clinical trials: A post-hoc study in the phase 2 and 3 ANIFROLUMAB clinical trials (Journal Article)
| <Specific Information> <Reference List> | |
| Type: | Journal Article |
| National /International: | International |
| Title: | Validation of the SLE-DAS responder index as an accurate and feasible endpoint for SLE clinical trials: A post-hoc study in the phase 2 and 3 ANIFROLUMAB clinical trials |
| Publication Date: | 2024 |
| Authors: |
- Carla Henriques
|
| Journal Name: | Annals of the Rheumatic Diseases |
| Volume: | 83, Supplement 1 |
| Pages: | 1004-1005 |
| Download: | Not available |
© Centre for Mathematics, University of Coimbra, funded by
Powered by: rdOnWeb v1.4 | technical support
Powered by: rdOnWeb v1.4 | technical support